Pharmacological Testing in Psychedelic Research
Receptor testing of the affinity and potency of compounds is a critical component of psychedelic research.
Articles - Page 13
Catching Up with the Psychedelic Entourage Effect: Part 4 – CaaMTech
Patent filings indicate that CaaMTech was the first company to propose an entourage effect in psychedelic compounds.
Ayahuasca’s Role in the Entourage Effect and Depression
Research suggests that DMT may not be the only compound responsible for ayahuasca's effects.
Psychedelics Show Promise for Treating Dementia
“…this stands up to scientific rigor and is worthy of further exploration.”
Catching Up with the Psychedelic Entourage Effect: Part 3 – Field Trip Discovery
This company is approaching psychedelic mushroom research literally from the ground up.
Insight into Ayahuasca’s Antidepressant Effects
Research indicates that C-Reactive Protein may play a vital role in combating Treatment-Resistant Depression.
New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
Serotonin and the Mental Organs Hypothesis
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.
Researchers Synthesize Novel Compound, Tabernanthalog, a Non-Hallucinogenic Ibogaine Analog
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
Ibogaine vs. Iboga Alkaloids for Treating Addiction
Novel chemical variants of ibogaine may offer therapeutic benefits without severe side effects.